Lupin Gets FDA OK for Cholesterol Drug

Aug 10, 2017

Economic Times

Mumbai-based Lupin has received approval from the U.S. FDA to market Pitavastatin tablets, used for lowering cholesterol.

Lupin's Nikita Pitavastatin tablets are a generic version of Kowa Company’s Livalo tablets. According to Lupin, As per IMS MAT June 2017 data, Livalo tablets had sales of $272 million in the U.S.

Nikita is ideal for patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotien B, triglycerides and to increase high-density lipoprotein cholesterol, says Lupin.

Read the ET coverage

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments